Reeve Emma insider trades
Reeve Emma has filed 24 Form 4s with the SEC that we hold, for Ptc Therapeutics, INC. (PTCT) (Director), Whitehawk Therapeutics, Inc. (WHWK) (Director), Editas Medicine, Inc. (EDIT) (Director) and CNST (Chief Financial Officer). Across all of them we count 0 purchases worth $0 and 27 sales worth $6.0M reported on Form 4. In the last 12 months: 0 purchases ($0) and 6 sales ($2.5M). The largest single trade was a sale of 12,000 shares of Ptc Therapeutics, INC. worth $834.0K, dated 2025-10-30. The first filing on our record is dated 2021-07-19 and the latest 2026-06-15.
Ptc Therapeutics, INC. (PTCT)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-04-21 | S, sale reported on Form 4 | 100 | $5.6K | 2023-04-25 |
| 2023-04-21 | S, sale reported on Form 4 | 4,228 | $232.7K | 2023-04-25 |
| 2023-05-22 | S, sale reported on Form 4 | 2,995 | $178.3K | 2023-05-24 |
| 2023-05-22 | S, sale reported on Form 4 | 173 | $10.3K | 2023-05-24 |
| 2023-05-22 | S, sale reported on Form 4 | 3,948 | $235.0K | 2023-05-24 |
| 2023-05-23 | S, sale reported on Form 4 | 157 | $9.3K | 2023-05-24 |
| 2023-05-23 | S, sale reported on Form 4 | 1,093 | $65.1K | 2023-05-24 |
| 2023-05-23 | S, sale reported on Form 4 | 1,402 | $83.5K | 2023-05-24 |
| 2025-09-11 | S, sale reported on Form 4 | 837 | $49.8K | 2025-09-16 |
| 2025-09-11 | S, sale reported on Form 4 | 3,534 | $210.3K | 2025-09-16 |
| 2025-09-11 | S, sale reported on Form 4 | 1,334 | $79.4K | 2025-09-16 |
| 2025-09-11 | S, sale reported on Form 4 | 10,000 | $595.0K | 2025-09-16 |
| 2025-10-03 | S, sale reported on Form 4 | 1,600 | $107.1K | 2025-10-07 |
| 2025-10-03 | S, sale reported on Form 4 | 2,729 | $177.5K | 2025-10-07 |
| 2025-10-03 | S, sale reported on Form 4 | 4,037 | $266.8K | 2025-10-07 |
| 2025-10-03 | S, sale reported on Form 4 | 1,884 | $126.0K | 2025-10-07 |
| 2025-10-03 | S, sale reported on Form 4 | 2,163 | $140.6K | 2025-10-07 |
| 2025-10-03 | S, sale reported on Form 4 | 2,381 | $159.2K | 2025-10-07 |
| 2025-10-03 | S, sale reported on Form 4 | 3,149 | $208.2K | 2025-10-07 |
| 2025-10-03 | S, sale reported on Form 4 | 3,028 | $197.1K | 2025-10-07 |
| 2025-10-03 | S, sale reported on Form 4 | 4,591 | $303.4K | 2025-10-07 |
| 2025-10-30 | S, sale reported on Form 4 | 3,666 | $254.8K | 2025-10-31 |
| 2025-10-30 | S, sale reported on Form 4 | 12,000 | $834.0K | 2025-10-31 |
| 2025-11-12 | S, sale reported on Form 4 | 7,333 | $546.3K | 2025-11-14 |
| 2025-11-21 | S, sale reported on Form 4 | 10,000 | $795.0K | 2025-11-25 |
| 2025-12-03 | S, sale reported on Form 4 | 733 | $57.6K | 2025-12-05 |
| 2026-01-05 | S, sale reported on Form 4 | 734 | $55.8K | 2026-01-06 |
Whitehawk Therapeutics, Inc. (WHWK)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Editas Medicine, Inc. (EDIT)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
CNST
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1680329) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms